Pulmonary arterial hypertension (PAH) is a rare and progressive cardiopulmonary disease,
characterized by pulmonary vasculopathy. The disease can lead to increase pulmonary …

Patients with pulmonary arterial hypertension (PAH) who are admitted to the intensive care
unit (ICU) pose a challenge to the multidisciplinary health-care team due to the complexity of …

Pulmonary artery pressure elevation complicates the course of many complex disorders
treated in a noncardiac intensive care unit. Acute pulmonary hypertension, however …

Pulmonary arterial hypertension (PAH) is a progressive disease characterized by a
vasculopathy that results in sustained elevation of pulmonary artery pressures, which …

Pulmonary hypertension (PH) is a condition associated with high morbidity and mortality.
Patients with PH who require critical care usually have severe right ventricular (RV) …

Pulmonary arterial hypertension (PAH) is characterized by progressive remodeling of small
pulmonary arteries leading to elevated pulmonary vascular resistance and right-heart …

Pulmonary arterial hypertension is a rare and progressive disease with significant morbidity
and mortality risk. Several medications targeting three major disease pathways are …

Most patients with pulmonary arterial hypertension succumb to their disease in the ICU;
however, limited evidence-based information exists to guide treatment in those that present …

Pulmonary hypertension (PH) is a complex disorder that was first described in a case report
as “pulmonary vascular sclerosis” in 1891 by German internist Dr Ernst von Romberg. 1 …

Pulmonary arterial hypertension (PAH) is commonly treated with pulmonary arteriolar
vasodilator therapy. When a patient on PAH medication is admitted to intensive care …